06:59:09 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



Oncolytics Biotech Inc (2)
Symbol ONC
Shares Issued 14,981,602
Close 2018-05-31 C$ 8.20
Market Cap C$ 122,849,136
Recent Sedar Documents

Oncolytics Biotech shares approved for Nasdaq listing

2018-06-01 08:37 ET - News Release

Dr. Matt Coffey reports

ONCOLYTICS BIOTECH ANNOUNCES LISTING ON NASDAQ CAPITAL MARKET

Oncolytics Biotech Inc.'s shares of common stock were approved for listing on the Nasdaq Capital Market. Oncolytics Biotech's common stock will commence trading on the Nasdaq Capital Market today, June 1, 2018, under the symbol ONCY.

"Listing on Nasdaq, a premier U.S. stock exchange, represents another significant milestone for Oncolytics and our shareholders," said Dr. Matt Coffey, president and chief executive officer of Oncolytics Biotech. "As a Nasdaq-listed company, we expect to have the opportunity to broaden our exposure to biotech-focused institutional investors, diversify our shareholder base, expand our access to capital and increase the liquidity of our shares."

Oncolytics's common stock will continue to trade on the Toronto Stock Exchange (TSX) under the trading symbol ONC.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.